Market by Product and Service, Type, Application, Technology, Industry Verticals, and Country | Forecast 2021-2028
As per Triton’s report, the multiplex assay market in Europe is assessed to obtain a CAGR of 8.30% in terms of revenue during the forecasted phase of 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries examined in this market include:
• The United Kingdom
• Spain
• Germany
• Italy
• France
• Russia
• Rest of Europe
Europe’s multiplex assay market is likely to grow at a steady pace over the forecast period, owing to the rise of government focus towards technological advancements in medical devices, increase in healthcare expenditure, and well-developed healthcare systems. Along with this, the high prevalence of chronic diseases, coupled with the increase in the geriatric population, is estimated to contribute to the growth of the multiple assay market in the next few years.
Furthermore, the studied market is mainly driven by the rise in the pharmaceutical industry and clinical trials across Germany. In this regard, multiplex assay technology is anticipated to help pharma companies lower clinical trial costs by reducing approval time. Besides, the country is among the significant destinations for pharmaceutical research and development. Thus, the extensive research activities in the pharma industry are likely to drive the use of digital PCR, opening new avenues for the multiplex assay market during the assessed period.
Furthermore, governmental support to domestic and international organizations to set up new manufacturing centers to expand R&D activities is likely to fuel the growth of the German multiplex assay market over the forecast period.
Randox Laboratories Ltd is a clinical diagnostic company that offers clinical diagnostic solutions to laboratories. Its product line includes biochip analyzers, clinical chemistry analyzers, biochip immunoassays, and diagnostic reagents. In addition, it provides diagnostic, prognostic, and predictive solutions for cardiovascular diseases, cancer, and others. Randox has operations across various regions, with headquarters in the United Kingdom.
1. EUROPE
MULTIPLEX ASSAY MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON MULTIPLEX ASSAY MARKET
2.2. KEY
INSIGHTS
2.3. PORTER’S
FIVE FORCES MODEL
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. COMPETITIVE
RIVALRY
2.4. KEY
BUYING OUTLOOK
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. KEY
MARKET STRATEGIES
2.7.1. CONTRACTS
AND PARTNERSHIPS
2.7.2. BUSINESS
EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES
2.7.3. ACQUISITIONS
& MERGERS
2.7.4. NEW
PRODUCT LAUNCHES & DEVELOPMENTS
2.8. KEY
DRIVERS
2.8.1. ADOPTION
OF PERSONALIZED MEDICINES
2.8.2. HIGH
ADOPTION OF MULTIPLEX ASSAYS OVER TRADITIONAL METHODS
2.9. KEY
RESTRAINTS
2.9.1. DEARTH
OF SKILLED PROFESSIONALS
2.9.2. LEGAL
TRENDS RELATED TO ENVIRONMENTAL SAFETY
2.10. KEY
OPPORTUNITIES
2.10.1. FUNDING
FOR R&D ACTIVITIES BY VARIOUS GOVERNMENT AGENCIES AND COMPANIES
3. EUROPE
MULTIPLEX ASSAY MARKET - BY PRODUCT AND SERVICE
3.1. REAGENTS
AND CONSUMABLES
3.2. INSTRUMENTS
AND ACCESSORIES
3.3. SOFTWARE
AND SERVICES
4. EUROPE
MULTIPLEX ASSAY MARKET - BY TYPE
4.1. PROTEIN-BASED
MULTIPLEX ASSAY
4.2. NUCLEIC
ACID-BASED MULTIPLEX ASSAY
4.3. OTHER
MULTIPLEX ASSAYS
5. EUROPE
MULTIPLEX ASSAY MARKET - BY APPLICATION
5.1. RESEARCH
AND DEVELOPMENT
5.2. CLINICAL
DIAGNOSTICS
5.3. COMPANION
DIAGNOSTICS
6. EUROPE
MULTIPLEX ASSAY MARKET - BY TECHNOLOGY
6.1. MULTIPLEX
PROTEIN MICROARRAY
6.2. MULTIPLEX
PCR
6.3. OTHER
TECHNOLOGIES
7. EUROPE
MULTIPLEX ASSAY MARKET - BY INDUSTRY VERTICALS
7.1. PHARMACEUTICAL
& BIOTECHNOLOGY COMPANIES
7.2. RESEARCH
INSTITUTES
7.3. CLINICAL
LABORATORIES
7.4. HOSPITALS
8. EUROPE
MULTIPLEX ASSAY MARKET – COUNTRY OUTLOOK
8.1. COUNTRY
ANALYSIS
8.1.1. GERMANY
8.1.2. FRANCE
8.1.3. UNITED
KINGDOM
8.1.4. ITALY
8.1.5. RUSSIA
8.1.6. SPAIN
8.1.7. REST
OF EUROPE
9. COMPETITIVE
LANDSCAPE
9.1. ABCAM
9.2. AGILENT
TECHNOLOGIES INC
9.3. BECTON
DICKINSON AND COMPANY
9.4. BIO
RAD LABORATORIES INC
9.5. BIO
TECHNE CORPORATION
9.6. F
HOFFMANN LA ROCHE
9.7. ILLUMINA
INC
9.8. LUMINEX
CORPORATION
9.9. MERCK
MILLIPORE
9.10. MESO
SCALE DIAGNOSTICS LLC
9.11. OLINK
PROTEOMICS AB
9.12. QIAGEN
NV
9.13. RANDOX
LABORATORIES LTD
9.14. SEEGENE
INC
9.15. SIEMENS
HEALTHINEERS AG
9.16. THERMO
FISHER SCIENTIFIC INC
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.1.1. OBJECTIVES
OF STUDY
10.1.2. SCOPE
OF STUDY
10.2. SOURCES
OF DATA
10.2.1. PRIMARY
DATA SOURCES
10.2.2. SECONDARY
DATA SOURCES
10.3. RESEARCH
METHODOLOGY
10.3.1. EVALUATION
OF PROPOSED MARKET
10.3.2. IDENTIFICATION
OF DATA SOURCES
10.3.3. ASSESSMENT
OF MARKET DETERMINANTS
10.3.4. DATA
COLLECTION
10.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: EUROPE MULTIPLEX
ASSAY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: CONTRACTS AND PARTNERSHIPS
TABLE 4: LIST OF BUSINESS
EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES
TABLE 5: ACQUISITIONS &
MERGERS
TABLE 6: LIST OF NEW PRODUCT
LAUNCHES & DEVELOPMENTS
TABLE 7: EUROPE MULTIPLEX
ASSAY MARKET, BY PRODUCT AND SERVICE, 2021-2028 (IN $ MILLION)
TABLE 8: EUROPE MULTIPLEX
ASSAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: EUROPE MULTIPLEX
ASSAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 10: EUROPE MULTIPLEX ASSAY
MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 11: EUROPE MULTIPLEX ASSAY
MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 12: EUROPE MULTIPLEX ASSAY
MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 1: EUROPE MULTIPLEX ASSAY MARKET 2021-2028 (IN
$ MILLION)
FIGURE 2: EUROPE MULTIPLEX ASSAY MARKET, BY PRODUCT
AND SERVICE, 2020 & 2028 (IN %)
FIGURE 3: EUROPE MULTIPLEX ASSAY MARKET, BY REAGENTS
AND CONSUMABLES, 2021-2028 (IN $ MILLION)
FIGURE 4: EUROPE MULTIPLEX ASSAY MARKET, BY
INSTRUMENTS AND ACCESSORIES, 2021-2028 (IN $ MILLION)
FIGURE 5: EUROPE MULTIPLEX ASSAY MARKET, BY SOFTWARE
AND SERVICES, 2021-2028 (IN $ MILLION)
FIGURE 6: EUROPE MULTIPLEX ASSAY MARKET, BY TYPE,
2020 & 2028 (IN %)
FIGURE 7: EUROPE MULTIPLEX ASSAY MARKET, BY
PROTEIN-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)
FIGURE 8: EUROPE MULTIPLEX ASSAY MARKET, BY NUCLEIC
ACID-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)
FIGURE 9: EUROPE MULTIPLEX ASSAY MARKET, BY OTHER
MULTIPLEX ASSAYS, 2021-2028 (IN $ MILLION)
FIGURE 10: EUROPE MULTIPLEX ASSAY MARKET, BY APPLICATION,
2020 & 2028 (IN %)
FIGURE 11: EUROPE MULTIPLEX ASSAY MARKET, BY RESEARCH AND
DEVELOPMENT, 2021-2028 (IN $ MILLION)
FIGURE 12: EUROPE MULTIPLEX ASSAY MARKET, BY CLINICAL
DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 13: EUROPE MULTIPLEX ASSAY MARKET, BY COMPANION
DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 14: EUROPE MULTIPLEX ASSAY MARKET, BY TECHNOLOGY,
2020 & 2028 (IN %)
FIGURE 15: EUROPE MULTIPLEX ASSAY MARKET, BY MULTIPLEX
PROTEIN MICROARRAY, 2021-2028 (IN $ MILLION)
FIGURE 16: EUROPE MULTIPLEX ASSAY MARKET, BY MULTIPLEX
PCR, 2021-2028 (IN $ MILLION)
FIGURE 17: ADVANTAGES OF IMMUNOHISTOCHEMISTRY (IHC)
FIGURE 18: EUROPE MULTIPLEX ASSAY MARKET, BY OTHER
TECHNOLOGIES, 2021-2028 (IN $ MILLION)
FIGURE 19: EUROPE MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICALS,
2020 & 2028 (IN %)
FIGURE 20: EUROPE MULTIPLEX ASSAY MARKET, BY
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 21: EUROPE MULTIPLEX ASSAY MARKET, BY RESEARCH
INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 22: EUROPE MULTIPLEX ASSAY MARKET, BY CLINICAL
LABORATORIES, 2021-2028 (IN $ MILLION)
FIGURE 23: EUROPE MULTIPLEX ASSAY MARKET, BY HOSPITALS,
2021-2028 (IN $ MILLION)
FIGURE 24: GERMANY MULTIPLEX ASSAY MARKET 2021-2028 (IN $
MILLION)
FIGURE 25: FRANCE MULTIPLEX ASSAY MARKET 2021-2028 (IN $
MILLION)
FIGURE 26: UNITED KINGDOM MULTIPLEX ASSAY MARKET
2021-2028 (IN $ MILLION)
FIGURE 27: ITALY MULTIPLEX ASSAY MARKET 2021-2028 (IN $
MILLION)
FIGURE 28: RUSSIA MULTIPLEX ASSAY MARKET 2021-2028 (IN $
MILLION)
FIGURE 29: SPAIN MULTIPLEX ASSAY MARKET 2021-2028 (IN $
MILLION)
FIGURE 30: REST OF EUROPE MULTIPLEX ASSAY MARKET
2021-2028 (IN $ MILLION)